See why thousands choose our centers as their preferred destination for ongoing care, including Crysvita treatments.
Crysvita is an infusion therapy that is indicated to treat:
- adults and children six months of age and older with X-linked hypophosphatemia (XLH).
Crysvita, also known as Burosumab-twza, is a biologic injection intended to treat adults and children six months of age and older with X-linked hypophosphatemia (XLH). It is typically administered every two weeks for pediatric patients and every four weeks for adult patients.
Patients chose IVX Health to receive their ongoing Crysvita treatments because:
- ALL private suites
- Comfortable recliners, with chairs for guests
- Evening & weekend appointments
- Friendly clinical staff deliver personal service
- Big screen TVs, high-speed WiFi, free snacks
Interested in moving your care to IVX Health?
Crysvita Financial Assistance Programs
Information about financial assistance programs coming soon.
Interested?
IVX Health would love to learn more about your care needs. If you’re interested in switching your infusion services – or if you just want to learn more – let us know.
